OPINION OF THE COURT
Appellant appeals from his conviction of unlawfully acquiring, concealing and transferring marihuana on two separate оccasions in violation of 26 U.S.C. §§ 4744(a) (1), 4744(a) (2) and 4742(a), respectively.
He claims he was denied due process of law when the governmеnt paid a known narcotics user to inform on him and then made no systematic effort to insure his availability at trial, even though the informer wаs an eye witness to the alleged crime. At the trial a special undercover narcotics agent testified that in response to a telephone call from a known narcotics user who was paid by the Government on a per diem basis for information, he went to the corner of Broad Street and Washington Avenue in Philadelphia, where he met the informer who introduced him to appellant. The agent bought three ounces of marihuana from appellant in the presence of the informer and another undercоver agent. After the sale appellant gave the agent a telephone number and told him to call that number and ask for John, if he desired to make further purchases. A week later after he had made a phone call to John the agent made a second purchase from appellant at another location in the City. The informer was not present during the transaction but the meeting was observed from a distance by the same agent who had witnessed the first sale. Appellant was arrested six months later and charged in a six-count indictment with the unlawful possession, concealment and sale of marihuana.
The claim is without merit. Though appellant knеw the informer and that he was present at the first sale, the defense made no attempt to learn of either his whereabouts priоr to trial or whether the prosecution was going to call him as a witness. The defense of entrapment was not asserted. No prosecutional misconduct had been established. The Government did not try to conceal the informer’s identity from the defense or that hе was present at the first sale. Moreover, the district court found on a sufficient explanation by the agents that the Government madе a reasonable effort to produce the informer at trial. Although the details of the
*450
part played by the informer in the first sale аnd his relationship with the appellant are unknown, the situation is not the equivalent of allowing the Government to withhold information forbidden in Roviaro v. United States,
Appellant’s other contention is that the proof did not sustain the verdicts in that the Government did not establish the identity of the substance transferred. The prosecution called to the stand a federally employed chemist who had inspected the substance received by the special agent from appellant on both occasions. He testified that he subjected the contents of each sample to a microscopic examination and to the Dukanoid test and concluded they were marihuana. On crоss-examination he stated that he knew of no other substance which would give a Dukanoid positive reaction. His answer to defensе counsel’s question “Can you tell the difference between Cannabis sativa and Cannabis indica” was no. By reason of the latter answеr, appellant argues that the government had not met its burden of proving the substances were marihuana because they may have been Cannabis indica, instead of Cannabis sativa L., and that only the latter substance is proscribed by the Internal Revenue Code. Befоre this argument may have any validity, Cannabis indica must in fact not be a substance called Cannabis sativa L. or marihuana.
Marihuana, a term of Mexican origin, is the dried leaves and flowering tops of a plant species commonly known as hemp. Botanically, the hemp plant is called Cannabis sativa L.
1
There is only one species of this plant. Leary v. United States,
The judgment of the District Court will be affirmed.
Notes
. The statutory definition of marihuana appears in 26 U.S.C. § 4761(2), as follоws :
' “Marihuana. — The term marihuana means all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extrаcted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such рlant, its seeds, or resin; but shall not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, de- " rivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.”
. “The hemp plant of India has been considered by some as a distinct species, and named Cannabis indica; but the most observant botanists, upon cоmparing it with our cultivated plant, have been unable to discover any specific difference. It is now, therefore, regarded mеrely as a geographical variety. Pereira states that in the female plant the flowers are somewhat more crowdеd than in the common hemp, but that the male plants in the two varieties are in all respects the same.” The Dispensatory of the United States, 22nd Ed., (Lippincott, 1940), p. 275. Also see Hearings before the Committee on Ways & Means, House of Representatives, 75th Cong., 1st Sess. (H.R.6385) pp. 18-19, 37-38, 55.
.
